Heritage Investors Management Corp Trims Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Heritage Investors Management Corp lessened its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 1.9% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 7,987 shares of the biotechnology company’s stock after selling 156 shares during the period. Heritage Investors Management Corp’s holdings in Axon Enterprise were worth $3,192,000 as of its most recent SEC filing.

Several other institutional investors also recently added to or reduced their stakes in the stock. Vanguard Group Inc. increased its stake in Axon Enterprise by 2.7% in the 1st quarter. Vanguard Group Inc. now owns 8,143,306 shares of the biotechnology company’s stock worth $2,547,878,000 after buying an additional 212,401 shares during the period. Motley Fool Asset Management LLC grew its holdings in Axon Enterprise by 238.7% during the 1st quarter. Motley Fool Asset Management LLC now owns 492,140 shares of the biotechnology company’s stock worth $153,981,000 after acquiring an additional 346,838 shares in the last quarter. 1832 Asset Management L.P. grew its holdings in Axon Enterprise by 44.0% during the 2nd quarter. 1832 Asset Management L.P. now owns 375,700 shares of the biotechnology company’s stock worth $110,546,000 after acquiring an additional 114,800 shares in the last quarter. Allspring Global Investments Holdings LLC grew its holdings in Axon Enterprise by 13.9% during the 2nd quarter. Allspring Global Investments Holdings LLC now owns 368,732 shares of the biotechnology company’s stock worth $108,496,000 after acquiring an additional 45,049 shares in the last quarter. Finally, Thrivent Financial for Lutherans grew its holdings in Axon Enterprise by 1.6% during the 2nd quarter. Thrivent Financial for Lutherans now owns 270,430 shares of the biotechnology company’s stock worth $79,571,000 after acquiring an additional 4,365 shares in the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Insider Buying and Selling

In related news, Director Michael Garnreiter sold 1,000 shares of Axon Enterprise stock in a transaction that occurred on Tuesday, October 15th. The shares were sold at an average price of $437.98, for a total value of $437,980.00. Following the completion of the sale, the director now directly owns 26,259 shares in the company, valued at $11,500,916.82. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In related news, Director Michael Garnreiter sold 1,000 shares of Axon Enterprise stock in a transaction that occurred on Tuesday, October 15th. The shares were sold at an average price of $437.98, for a total value of $437,980.00. Following the completion of the sale, the director now directly owns 26,259 shares in the company, valued at $11,500,916.82. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Patrick W. Smith sold 4,767 shares of Axon Enterprise stock in a transaction that occurred on Thursday, October 3rd. The stock was sold at an average price of $404.14, for a total transaction of $1,926,535.38. Following the completion of the sale, the chief executive officer now owns 2,925,060 shares of the company’s stock, valued at $1,182,133,748.40. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 371,172 shares of company stock worth $137,000,162 in the last three months. Corporate insiders own 5.70% of the company’s stock.

Axon Enterprise Stock Up 2.2 %

AXON stock opened at $441.09 on Wednesday. The firm has a 50 day moving average of $403.76 and a 200 day moving average of $342.09. The stock has a market capitalization of $33.33 billion, a PE ratio of 116.38, a price-to-earnings-growth ratio of 10.99 and a beta of 0.94. The company has a quick ratio of 2.52, a current ratio of 2.88 and a debt-to-equity ratio of 0.35. Axon Enterprise, Inc. has a 52 week low of $212.88 and a 52 week high of $455.17.

Axon Enterprise (NASDAQ:AXON) last released its earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 EPS for the quarter, topping analysts’ consensus estimates of $1.02 by $0.18. The company had revenue of $504.00 million during the quarter, compared to analysts’ expectations of $478.35 million. Axon Enterprise had a net margin of 16.06% and a return on equity of 9.34%. Axon Enterprise’s revenue for the quarter was up 34.5% on a year-over-year basis. During the same period last year, the business earned $0.80 EPS. Sell-side analysts forecast that Axon Enterprise, Inc. will post 1.79 earnings per share for the current year.

Analysts Set New Price Targets

Several research analysts have issued reports on AXON shares. JMP Securities increased their target price on shares of Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a report on Thursday, October 31st. Jefferies Financial Group started coverage on shares of Axon Enterprise in a report on Wednesday, July 17th. They set a “buy” rating and a $385.00 target price on the stock. Northland Securities increased their target price on shares of Axon Enterprise from $330.00 to $365.00 and gave the stock an “outperform” rating in a report on Thursday, August 8th. Needham & Company LLC increased their target price on shares of Axon Enterprise from $400.00 to $525.00 and gave the stock a “buy” rating in a report on Tuesday, October 22nd. Finally, Robert W. Baird increased their target price on shares of Axon Enterprise from $440.00 to $460.00 and gave the stock an “outperform” rating in a report on Monday. Two research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $392.85.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.